Clinical Trial Update: Loratadine for Improvement of Bone Pain in Patients With Chronic Granulocyte-Colony Stimulating Factor (G-CSF) Use [Phase 2]

View source ↗

Summary

Phase 2 trial update for loratadine intended to improve bone pain in patients using G-CSF; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Pain Conditions Related to Chronic G-csf Use

Drugs mentioned

• Loratadine (Loratadine)

Snippet

Sponsor: University of Michigan | Conditions: Bone Pain | Phase 2 | Status: TERMINATED | Results posted: 2020-10-22